AlloSource, Inc., a leading provider in the regenerative medicine industry, is headquartered in the United States. Founded in 1994, the company has established itself as a pioneer in the development and distribution of innovative allograft tissue products. With a focus on enhancing patient outcomes, AlloSource offers a diverse range of core services, including bone, cartilage, and soft tissue allografts, which are distinguished by their rigorous quality standards and advanced processing techniques. Operating primarily in the US, AlloSource has achieved significant milestones, including numerous regulatory approvals and partnerships with healthcare providers. The company is recognised for its commitment to research and development, positioning itself as a trusted leader in the market. With a strong emphasis on safety and efficacy, AlloSource continues to make strides in the field of tissue transplantation, ultimately improving the lives of patients across the nation.
How does AlloSource, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AlloSource, Inc.'s score of 25 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AlloSource, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, AlloSource's climate commitments and initiatives remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or contributing to climate action. The lack of data may reflect a broader industry context where companies are increasingly expected to disclose their environmental impact and set measurable targets for emissions reduction. Without specific emissions data or commitments, it is challenging to assess AlloSource's position in the context of climate responsibility and sustainability efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AlloSource, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.